We are live on
!
Find out more
FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
230 hedge funds and large institutions have $3.57B invested in Amicus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 91 increasing their positions, 64 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
11% more capital invested
Capital invested by funds: $3.2B → $3.57B (+$367M)
4% more funds holding
Funds holding: 222 → 230 (+8)
5.45% less ownership
Funds ownership: 109.55% → 104.1% (-5.5%)
Holders
230
Holding in Top 10
7
Calls
$8.86M
Puts
$7.25M
Top Buyers
| 1 | +$55.7M | |
| 2 | +$13.2M | |
| 3 | +$11.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.51M |
| 5 |
Morgan Stanley
New York
|
+$7.38M |
Top Sellers
| 1 | -$179M | |
| 2 | -$19.6M | |
| 3 | -$19.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.2M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$16.5M |